Postal Service Eyes January Rate Hikes

Deluxe announced its integration with Q2 Holdings, Inc. (NYSE: QTWO), a leading provider of digital transformation solutions for banking and lending. Through this integration, Deluxe will offer HR & Payroll Solutions within Q2’s Partner Marketplace Program, enabling financial institutions to seamlessly provide these solutions to their clients, while generating recurring revenue and increasing customer retention. The Q2 Partner Marketplace allows financial service companies to provide applications to their consumer and small business clients. The Deluxe HR & Payroll application offered through the Q2 Marketplace, empowers small businesses to automate payroll, tax payments, hiring and onboarding, time management, benefits administration, and additional HR tools within a single platform for ease of use.

Net sales for the quarter increased 14.7 percent, to $43.89 billion, from $38.26 billion last year. Net sales for the first 24 weeks increased 15.8 percent, to $86.23 billion, from $74.49 billion last year. Net income for the quarter was $951 million, or $2.14 per diluted share, which includes $246 million pretax, or $0.41 per diluted share, in costs incurred primarily from COVID-19 premium wages. Last year’s second quarter net income was $931 million, or $2.10 per diluted share. Net income for the first 24 weeks was $2.12 billion, or $4.76 per diluted share, compared to $1.77 billion, or $4.00 per diluted share, last year. For the four-week reporting month of February, ended February 28, 2021, the Company reported net sales of $14.05 billion, an increase of 15.2 percent from $12.20 billion last year. For the twenty-six week period ended February 28, 2021, net sales were $93.16 billion, an increase of 15.4 percent from $80.76 billion last year.

Fiscal 2018 first quarter net earnings attributable to Walgreens Boots Alliance determined in accordance with GAAP decreased 22.1 percent to $821 million compared with the same quarter a year ago, while GAAP diluted net earnings per share decreased 16.5 percent to $0.81 compared with the same quarter a year ago. The decreases in GAAP net earnings and GAAP net earnings per share were mainly due to impairment of the company's equity method investment in Guangzhou Pharmaceuticals. In addition, these decreases reflect a loss from the company's equity earnings in AmerisourceBergen and benefits from the UK tax rate reduction recorded in the same quarter a year ago. Sales in the first quarter were $30.7 billion, an increase of 7.9 percent from the year-ago quarter, and an increase of 7.2 percent on a constant currency basis. Click Read More below for additional information.